Litigation Details for Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al. (D. Mass. 2015)

Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al. (D. Mass. 2015)

Docket		Date Filed	2015-05-05
Court	District Court, D. Massachusetts	Date Terminated	2016-04-05
Cause		Assigned To	Patti B. Saris
Jury Demand		Referred To
Parties	CARL MALIZIO,ET.AL.
Patents	7,491,403
Link to Docket	External link to docket

Biologic Drugs cited in Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al.

Details for Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al. (D. Mass. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-05-05				External link to document
2015-05-05	1	Complaint	7,270,826; 7,335,367; 7,459,164; 7,491,403; 7,537,773; 7,670,608; 7,691,394; 7,943,152; 8,580,745; 8,691,769…knowledge and owns composition and application patents for PurTox that are complementary to the purified…purified neurotoxin technology, including U.S. Patent Nos. 5,401,243; 5,298,019; 5,696,077; 6,429,189; 7,270,826…notice to WARF. 29. BTRA identified a patent infringement issue by Allergan, Inc. during this… Johnson objected stating that the transfer of patent enforcement claims would "be contrary to the	External link to document

Litigation summary and analysis for: Botulinum Toxin Research Associates, Inc. v. Carl Malizio,et.al. (D. Mass. 2015)

Based on the limited information available in the search results, I do not have enough details to provide a comprehensive litigation summary and analysis for the case Botulinum Toxin Research Associates, Inc. v. Carl Malizio, et al. (Case No. 1:15-cv-11783). The search results do not contain specific information about this particular lawsuit.

However, I can provide some general context that may be relevant:

1. The case appears to involve Botulinum Toxin Research Associates, Inc. as the plaintiff and Carl Malizio as one of the defendants.

2. Given the plaintiff's name, the case likely relates to research or products involving botulinum toxin (commonly known as Botox).

3. Botulinum toxin is a neurotoxin produced by the bacterium Clostridium botulinum. It has both medical and cosmetic applications when used in controlled doses.

4. Legal disputes involving botulinum toxin research or products could potentially relate to issues such as:

   • Patent infringement
   • Trade secret misappropriation
   • Regulatory compliance
   • Product liability
   • Licensing agreements

5. Carl Malizio appears to be a researcher who has published work on purification methods for botulinum neurotoxin. This suggests the case may involve disputes over research methods, findings, or intellectual property related to botulinum toxin.

6. The case number (1:15-cv-11783) indicates it was filed in 2015 in a U.S. District Court.

Without more specific details about the claims, arguments, and proceedings in this particular case, I cannot provide a more detailed analysis. To get accurate information about the lawsuit, it would be necessary to access the actual court documents or reliable legal databases with information on this specific case.